logo




Nicola Dioguardi

Nico la Dioguardi, MD

Scientific Superintendent
Istituto Clinico Humanitas

 

 

 

Education
1939-1945: MD cum laude from the University of Bologna: the thesis, The question of Banti’s disease, was judged “worthy of publication” and was also award the Augusto Murri Prize for the the best medical degree thesis of that academic year. This period also involved attendance at Institute of Pathological Anatomy and, during the last two years, the Institute of Medical Pathology at Bologna’s Ospedale S. Orsola.

Experience
1946-1948 - Clinical Medicine, University of Catania.
1951 - Assistant and then Deputy Head of Clinical Medicine, University of Milan
1963-1964 - Lecturer, University of Cagliari
1967 - Professor of Medical Pathology, University of Cagliari
1968 - Founder of the Migliavacca Centre for the Study of Liver and Biliary Pathway Diseases, the Centre for the Study of Pre-cancerous States of the Digestive Tract, and the Centre for the Study of Pre-cancerous States of the Liver.
1968-1970 - Professor of Medical Semeiotics and Director of the corresponding Clinical institute, University of Milan
1970-1973 - Professor and Director of the Institute of Medical Pathology, University of Milan
1974-1984 - Professor and Director of the Institute of Clinical Medicine III, University of Milan. Established and directed the Post-graduate Schools of Gastroenterology, Hematology and Gerontology.
Founder of the Gruppo di Medici e Sistemisti di Via Pace at the Institute of Internal Medicine, and of the Centre of Theoretical Medicine Studies of the University of Milan
1984-1991 - Professor and Director of the Institute of Internal Medicine, University of Milan
1987 - Founder of Istituto Clinico Humanitas, considered the most modern Italian hospital in terms of its technical and operational conception.
1992-2005 - Scientific Director of Istituto Clinico Humanitas.
2001-present - Scientific Director of Fondazione Michele Rodriguez.
2001-present - Founder and Director, within Istituto Clinico Humanitas, of the Laboratory for the Study of Metric Measures in Medicine, which is sponsored by Fondazione Michele Rodriguez.
2005-present Superintendant of Scientific Research, Istituto Clinico Humanitas.

 
Scientific Profile
Prof. Nicola Dioguardi entered the Medical Faculty of the University of Bologna at the beginning of the II World War, a period in which new forms of analysis were being developed in the field of medicine as a practical science. At that time, the use of statistics was spreading as a means of evaluating quantified propositions describing the qualities of human organs and apparatuses. The concept of quantity was beginning to be seen as the key element in the conception of science, and its symbolism was also being introduced as a part of the knowledge of medicine.
At a time in which medical research tended to be based on purely qualitative means of classifying the observed, Dioguardi started his own research work by studying the transmethylation of the amides of nicotinic acid, a molecular component of the oxidative cell chain. After beginning his university career, he developed his clinical and speculative interests in internal medicine particularly in the areas of hepatology, gastroenterology and hematologia, concentrating on the clinical applications of biochemistry. He qualified as a teacher of Internal Medicine and became a Director of Clinical Institutes at the Università di Cagliari and, three later, the University of Milan. In both places, he set and coordinated groups to study the characteristics of the enzyme systems of erythrocytes and white blood cells, and mitochondria isolated from the liver of rodents; these studies were among the first to document the anti-oxidative activity of vitamin E. Particular attention was given to the behaviour of the molecular forms of the lactate-dehydrogenases of these cells, and in the serum of normal blood and blood affected by some pathological states, as well as to studying liver tissue homogenates. He also studied lipid metabolism with a group of cardiologists. This phase of his research, which was founded on qualitative criteria, was aimed at classifying the natural and pathological states of liver function in the light of general systems theory, and he continued by applying the concepts of Rashevsky’s relational biology and then (RM)-systems according to Robert Rosen. These studies led to the official report of the National Congress of the Society of Internal Medicine (Rome 1982), and Masson’s publication of his book Il fegato un sistema aperto [The liver: an open system], the first outline of a machine for quantitative studying the dynamics of the metabolism of cells cultivated in vitro. This machine has now been patented and is called a “metaboliser” in his laboratory. This phase also led to another book Fegato a più dimensioni [The multi-dimensional liver], which was published by Etas Libri.
The result of this series of research studies led Dioguardi to conclude that: 1) the description of the liver as an open system suggested by the General Systems Theory provided an exhaustive laguage for defining the organ a functional body; 2) the assembly of very different structures which, for some functions, are dispersed in interacting sub-systems having the same function, to classify the actions and functional behaviours of diseases in clear terms; and 3) functional-structural descriptions apply an extraordinary language in order to discriminate dispersed elements belonging to clearly identifiable sub-systems of the complex function of the organ. 
In more strictly clinical terms, Dioguardi reviewed the debate between quantitative definition and the semi-quantitative descriptions with which hepatological disciplines confront the problem of interpreting liver biopsies, and began to explore the metric measurement and geometry of hepatic lesions caused by chronic viral inflammation on the basis of the mathematical precepts underlying the most modern theory of measurement (fractal theory). This brought to light the tension provoked by the differences between semiquantitative and (geometrico-mathematical) quantitative findings (i.e. between empirical and mathematical reality, at a time in which the latter was experiencing renewed uncertainties as to its infallibility induced by Goedel’s principle of incalculability), and led him to reflect on the measurability of a complex organ belonging to a living system, about which doubts were raised because of our incomplete knowledge of it, and the elements capable of representing its essence. This involves distinguishing the significance of the elements that can best be used as formalisms on which to base biological (and not only mathematical) interpretations founded on reason, the demonstration of theorems, and the identification of concepts from which new knowledge can be drawn.
This mental position led Dioguardi to interpret such formalisms automatically, and to design a rapid and user-friendly automatic machine that can provide within a few minutes a quantitative index of the metrical variations of the state changes caused by the hepatocellular mass (necrosis), the topical immune system (inflammation) and the collagenous component (fibrosis) of liver tissue, and the consequent changes in (i.e. loss of) the order of tissue tectonics. The intent is to standardise:
1)    measuring large numbers of biopsies in a short time
2)    obtaining rigorous and repeatable results
3)    discovering the unknown but measurable physical characteristics of the objects being examined
4)    respecting the ethical principle that, as the aggressiveness of bioptic examinations involves a small risk for the patient, in addition to entrusting them to expert hands the tissue specimen obtained must be interpreted as precisely as possible.
It can be seen that such studies not only respond to the theoretical challenge of the transition from semi-quantitative to quantitative medicine, but above all from the conviction that the results of the research can have a practical impact on patient well-being and offer advantages in relation to health policies. In economic terms, diagnostic certainty will reduce costs as a result of correct therapeutic indications and the possibility of making predictions, and the utmost rigour in performing biopsies will certainly lead to improvements in the ethics related to the manoeuvre.
This means that the type of research carried out by Dioguardi will have both a social and economic impact. The lower costs associated with automatic biopsy readings and diagnoses will reduce expenditure at a time in which welfare systems are going through an economic crisis.
 
Honours and awards
Three times awarded the Gold Medal for Civic Merit by the Civiche Benemerenze of Milan City Council
Awarded the Gold Medal for Services to Culture and Science by the Ministry of Education
Nominated Cavaliere di Gran Croce della Repubblica Italiana, by the President of the Italian Republic
Honorary Member of the Italian Society of Internal Medicine
Honorary Member of the Italian Society of Radiology
Member of the Istituto Lombardo di Scienze e Lettere, Milan
Member of the Istituto Veneto di Scienze e Lettere, Venice
Career Prize at the V Giornate della Scuola Medica Salernitana
Rudolph L.K. Virchow Award

 

TOOLS

Send

Print

Istituto Clinico Humanitas Humanitas Gavazzeni Humanitas Centro Catanese
di Oncologia
Humanitas Mater Domini Clinica Cellini
Il giornale della salutewww.humanitasalute.it Check up e Second Opinionwww.humanitasonline.com Fondazione per la ricercawww.humanitasricerca.org Fondazione Humanitaswww.fondazionehumanitas.it Fondazione Arielwww.fondazioneariel.it